Related Experiment Video

Updated: Dec 13, 2025

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

17.2K

Chemokines in bone-metastatic breast cancer: Therapeutic opportunities

Yucheng Wang1, Shihong Ren2, Zhan Wang3

  • 1Hebei North University, Zhangjiakou, China.

International Immunopharmacology
|July 26, 2020
PubMed

Insights

Targeting chemokine networks offers a promising strategy for treating bone metastasis in breast cancer, addressing challenges like chemotherapy resistance and immune evasion. This approach aims to improve outcomes for patients with this difficult-to-cure condition.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Breast cancer with bone metastasis is challenging to treat due to resistance to standard therapies like chemotherapy and checkpoint inhibitors.
  • Chemokines, small proteins crucial for cell migration and immunity, play dual roles (pro-tumor or anti-tumor) within the breast cancer tumor microenvironment.
  • These roles can be immunosuppressive or immunostimulatory, depending on their source (cancer cells or immune cells).

Purpose of the Study:

  • To review the intricate roles of chemokine networks in the biology of breast cancer bone metastasis.
  • To explore the therapeutic potential of targeting these chemokine networks for treating bone-metastatic breast cancer.
  • To discuss future prospects of combining chemokine-targeting strategies with existing therapies.

Main Methods:

  • Literature review focusing on chemokine networks in breast cancer bone metastasis.
  • Analysis of the dual roles of chemokines in the tumor microenvironment.
  • Discussion of therapeutic strategies targeting chemokine networks.

Main Results:

  • Chemokine networks significantly influence breast cancer metastasis to bone.
  • Chemokines secreted by cancer cells and immune cells exert complex, context-dependent effects on tumor progression.
  • Targeting chemokine networks presents a viable therapeutic avenue for bone-metastatic breast cancer.

Conclusions:

  • Understanding chemokine networks is critical for developing effective treatments for breast cancer bone metastasis.
  • Targeting chemokines, potentially in combination with other therapies, holds promise for improving patient outcomes.
  • Further research into chemokine-mediated interactions is warranted to optimize therapeutic strategies.
Keywords:
Bone metastasisBreast cancer (BC)ChemokineTumor immunitytumor microenvironment (TME)

More Related Videos

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

6.3K
Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines06:00

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

7.5K

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K